Elevance Health Inc traded at $338.98 this Friday February 6th, increasing $6.73 or 2.03 percent since the previous trading session. Looking back, over the last four weeks, Elevance Health gained 7.56 percent. Over the last 12 months, its price fell by 13.40 percent. Looking ahead, we forecast Elevance Health Inc to be priced at 335.09 by the end of this quarter and at 305.07 in one year, according to Trading Economics global macro models projections and analysts expectations.
Anthem, Inc. is a health benefits company. The Company operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. It also provides an array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. It provides an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits and radiology benefit management.